866-997-4948(US-Canada Toll Free)

In-vitro Colorectal Cancer Screening Tests (Fecal Occult Tests: Guaiac FOB Stool, Immuno-FOB Agglutination, Lateral Flow Immuno-FOB, Immuno-FOB ELISA; Stool Biomarker Tests: ColoGuard, M2-PK Stool Test, and Others; Blood Biomarker Tests: ColonSentry, ColoVantage, Epi proColon, mS9, and Others) Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023

Published By :

Transparency Market Research

Published Date : Sep 2015

Category :

Cancer

No. of Pages : 95 Pages

Colorectal cancer, also known as bowel cancer, colorectal adenocarcinoma, or colon cancer, is a type of cancer that results from uncontrolled growth of the cells of rectum or colon. Factors such as growing geriatric population, rising prevalence of colorectal cancer, technological advancement, introduction of non-invasive screening tests are driving the growth of the global in-vitro colorectal cancer screening tests market. This report studies the current scenario as well as future market potential for in-vitro colorectal cancer screening tests globally. This report comprises an elaborate executive summary, which includes a market snapshot that provides market dynamics of various segments and sub-segments that are included in the report in a precise manner. Moreover, executive summary comprises waterfall diagram, which reflects the market size of various segments in descending order.

A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global in-vitro colorectal cancer screening tests market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Global In-vitro Colorectal Cancer Screening Tests Market, Estimates and Forecast, By Revenue, 2015–2023 (US$ Mn)
2.2 Global Market Share by Geography, 2014 and 2023
2.3 Global In-vitro Colorectal Cancer Screening Tests Market, by Test Type 2014 (US$ Mn)
2.4 In-vitro Colorectal Cancer Screening Tests  Market Snapshot

Chapter 3 In-vitro Colorectal Cancer Screening Tests Market– Industry Analysis
3.1 Introduction
3.2 Epidemiology – In-vitro Colorectal Cancer Screening
3.3 Market Drivers
3.3.1 Increase in demand for rapid and non-invasive diagnostic tools and techniques
3.3.2 High prevalence of inherited syndromes, diabetes, and others
3.3.3 Increased awareness of colorectal cancer and health care expenditure globally
3.4 Restraints
3.4.1 Stringent and ambiguous regulatory environment
3.4.2 Reimbursement challenges
3.5 Opportunity
3.5.1 Shift from invasive to non-invasive diagnostic techniques
3.5.2 Increase in new technology in molecular-based diagnostic tests
3.6 Porter’s Five Forces Analysis 
3.7 Event Impact Analysis – In-Vitro Colorectal Cancer Screening Tests Market 
3.8 Market Share – In-Vitro Colorectal Cancer Screening Tests Market (2014) (%)  
3.9 Market Attractiveness Analysis – In-Vitro Colorectal Cancer Screening Tests Market 

Chapter 4 Market Segmentation – By Tests Type  
4.1 Introduction  
4.2 Global Fecal Occult Blood Tests Market , 2015–2023 (US$ Mn)  
4.2.1 Global Guaiac FOB Stool Test Market, 2015–2023 (US$ Mn) 
4.2.2 Global Immuno-FOB Agglutination Test Market, 2015–2023 (US$ Mn) 
4.2.3 Lateral Flow Immuno-FOB Test Market, 2015-2023(US$ Mn) 
4.2.4 Immuno-FOB ELISA Test Market, 2015-2023(US$ Mn) 
4.3 Stool Biomarker Tests Market , 2015–2023 (US$ Mn)  
4.3.1 ColoGuard Test Market, 2015–2023 (US$ Mn) 
4.3.2 M2-PK Stool Test Market, 2015–2023 (US$ Mn) 
4.3.3 Other Tests Market, 2015–2023 (US$ Mn) 
4.4 Blood Biomarker Tests Market, 2015–2023 (US$ Mn) 
4.4.1 ColonSentry Test Market, 2015–2023 (US$ Mn) 
4.4.2 ColoVantage Test Market, 2015–2023 (US$ Mn) 
4.4.3 Epi proColon Test Market, 2015–2023 (US$ Mn) 
4.4.4 mS9 Test Market, 2015–2023 (US$ Mn) 
4.4.4 Other tests Market, 2015–2023 (US$ Mn) 

Chapter 5 Pipeline Analysis 
5.1 Pipeline Analysis In-Vitro Colorectal Cancer Screening Market 

Chapter 6 Market Segmentation – Regional Analysis 
6.1 Regional Overview – In-vitro Colorectal Cancer Screening Tests Market 
6.2 North America In-vitro Colorectal Cancer Screening Tests Market, 2015–2023 (US$ Mn) 
6.3 Europe In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 
6.4 Asia Pacific In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 
6.5 Latin America In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 
6.6 RoW In-vitro Colorectal Cancer Screening Tests Market 2015–2023 (US$ Mn) 

Chapter 7 Recommendations 

Chapter 8 Company Profiles 
8.1 Abbott Laboratories, Inc.  
8.2 Alere, Inc. 
8.3 Beckman Coulter, Inc. 
8.4 Sysmex Corporation 
8.5 Quest Diagnostics, Inc 
8.6 Epigenomics AG 
8.7 Exact Sciences Corporation 
8.8 BioTime, Inc. 
8.9 CML Healthcare, Inc. 
8.10 Novigenix SA

List of Table

NA

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *